PanCytoVir

· TrippBio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PanCytoVir, covering 2023-08-25 to 2023-08-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy of PanCytoVir™ for the Treatment of Non-Hospitalized Patients With COVID-19 Infection [Phase 2]

See pricing